Integrated Cardiac Safety : Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $43.15
Usually ships in 1-2 business days
(Save 59%)
Other sellers (Hardcover)
  • All (10) from $43.15   
  • New (6) from $65.69   
  • Used (4) from $43.15   


The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: Surya M Artham, MD, MPH (Ochsner Clinic Foundation)
Description: This book nicely summarizes the importance of cardiac safety of drugs in the development process, pre-approval safety clinical trials, and post-approval surveillance.
Purpose: The prime objective of this book is to provide an overview of the steps involved in the approval of investigational agents, their associated cardiac safety issues, preclinical and clinical safety, and efficacy trials with these agents.
Audience: It is intended for pharmacists, clinical researchers, physicians, nurses, students, and allied healthcare professionals. It will be valuable to cardiovascular (CV) specialists and researchers interested in CV safety of cardiac and noncardiac therapeutic agents. The authors are well known and respected authorities in the field of clinical research in pharmacy.
Features: The book systematically highlights the steps involved in the approval of investigational agents for the market, specifically emphasizing the safety of these therapeutic agents on cardiac arrhythmias, generalized cardiac safety, and behavioral cardiac safety. The authors provide an in-depth review of the genetic pathways and other possible underlying mechanisms mediating adverse reactions of therapeutic agents. The book also covers the statistical methodologies applied in clinical trials, gives examples of some major CV drugs, and how and why they were taken off the market due to their adverse side effect profile. A noteworthy feature of this book is the way the authors cover the basics of all-important topics at the beginning of each chapter, making it easy to understand for newcomers in this field.
Assessment: This fills the void for a book addressing the safety issues, especially cardiac safety issues, of therapeutic agents in development. The content is high yield, easy to understand and succinct, covering the multiple steps involved in the drug safety and approval process.
From the Publisher
“This fills the void for a book addressing the safety issues, especially cardiac safety issues, of therapeutic agents in development. The content is high yield, easy to understand and succinct, covering the multiple steps involved in the drug safety and approval process.” (Doody's, April 2009)
Read More Show Less

Product Details

  • ISBN-13: 9780470229644
  • Publisher: Wiley
  • Publication date: 11/3/2008
  • Edition number: 1
  • Pages: 470
  • Sales rank: 1,508,833
  • Product dimensions: 6.30 (w) x 9.30 (h) x 1.10 (d)

Meet the Author

J. Rick Turner, PhD, PGCE, MICR, is Chairman, Department of Clinical Research at Campbell University School of Pharmacy. Dr. Turner has extensive teaching, research, and pharmaceutical credentials and more than a dozen awards and honors, including a Commit to Product Development Award from GlaxoSmithKline. He is the author of seven books and more than 100 journal articles and published abstracts. Todd A. Durham, MS, is Senior Director of Biostatistics and Data Management at Inspire Pharmaceuticals. Prior to joining Inspire, Mr. Durham served as Associate Director of Biostatistics at Quintiles, Inc. Mr. Durham has made significant statistical contributions to six NDA submissions and has been involved with five presentations to FDA advisory committees.

Read More Show Less

Table of Contents






1. The Importance of Cardiac Safety Assessments.

2. The Biological Basis of Adverse Drug Reactions.


3. Cardiac Structure and Function.

4. Cardiac Pathophysiology and Disease.


5. Drug Discovery and Drug Design.

6. Nonclinical Development.


7. The Thorough QT/QTc Trial.

8. General Safety Assessments.


9. Therapeutic Use Trials and Meta-analyses.

10. Assessment Methodologies in Nonexperimental Postmarketing Surveillance.

11. Postmarketing Proarrythmic Cardiac Safety Assessments.

12. Generalized Cardiac Safety.


13. Medication Errors, Adherence, and Concordance.


14. Future Directions in Drug Safety.



Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Terms of Use.
  • - Barnes & reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)